Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Moleculin Biotech Stock Price, Quotes and Forecasts | NASDAQ:MBRX | Benzinga

Q: What sector and industry does Moleculin Biotech (MBRX) operate in?

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Moleculin Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MBRX.

Open	$0.68
Close	$0.58
Volume / Avg.	1.31M / 599.28K
Day Range	$0.55 - $0.73
52 Wk Range	0.40 - 4.71
Market Cap	$8.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	4.3%
Days to Cover	3.06

Recent News

US Stocks Set For A Volatile Start: Analyst Dismisses Chances Of 20%+ S&P 500 Gain For Third Year In A Row, But Says 'Investors Should Be Optimistic'

U.S. stock futures traded close to the flatline on Friday after Tuesday's rally. Futures of all four benchmark indices were slightly lower.

Rishabh Mishra

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in late 2025, with another in 2026.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.68
Close	$0.58
Volume / Avg.	1.31M / 599.28K
Day Range	$0.55 - $0.73
52 Wk Range	0.40 - 4.71
Market Cap	$8.48M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	4.3%
Days to Cover	3.06

About Moleculin Biotech Inc

Sector

Health Care

Industry

Biotechnology

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a bro...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Moleculin Biotech (MBRX) stock?

You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.

View our list of the best stock brokerages

Who are Moleculin Biotech (MBRX) competitors?

Other companies in Moleculin Biotech’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Immuron (NASDAQ:IMRN), Intensity Therapeutics (NASDAQ:INTS), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the forecast, or price target, for Moleculin Biotech (MBRX) stock?

Moleculin Biotech has a consensus price target of $12.20.

What is the current price for Moleculin Biotech (MBRX)?

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $0.6 last updated June 18, 2025 at 7:57 PM EDT.

Does Moleculin Biotech (MBRX) pay a dividend?

There are no upcoming dividends for Moleculin Biotech.

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

Moleculin Biotech’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Moleculin Biotech (MBRX) going to split?

There is no upcoming split for Moleculin Biotech.

What sector and industry does Moleculin Biotech (MBRX) operate in?

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Moleculin Biotech Stock Price, Quotes and Forecasts

Moleculin Biotech (MBRX) Forecast